Report Content

Chapter 1.Methodology

1. Methodology
2. Market definitions
3. Forecast parameters
4. Data sources
   1. Secondary
      1. Paid sources
      2. Unpaid sources
   2. Primary

Chapter 2.Executive Summary

1. North America molecular diagnostics industry 360⁰ synopsis, 2013 - 2024
   1. Business trends
   2. Application trends
   3. Technology trends
   4. Regional trends

Chapter 3.North America Molecular Diagnostics Industry Insights

1. Industry segmentation
2. Industry landscape, 2013 - 2024
3. Industry impact forces
   1. Growth drivers
      1. Technological advancements and increasing awareness regarding early disease diagnosis
      2. Escalating demand for POC diagnostics
      3. Increasing geriatric population
      4. Increasing number of R&D activities
   2. Industry pitfalls and challenges
      1. Lack of clear and uniform regulatory framework
      2. Increasing cost of disease diagnostics
4. Growth potential analysis
   1. By application
   2. By technology
5. Regulatory landscape
   1. U.S.
6. Porter’s analysis
7. Competitive landscape, 2017
   1. Strategy dashboard
8. PESTEL analysis

Chapter 4.North America Molecular Diagnostics Market, By Application

1. Key segment trends
2. Infectious diseases
   1. Market size, by country, 2013-2024 (USD Million)
   2. Flu
      1. Market size, by country, 2013-2024 (USD Million)
   3. RSV virus
      1. Market size, by country, 2013-2024 (USD Million)
   4. Tuberculosis
      1. Market size, by country, 2013-2024 (USD Million)
   5. Meningitis
      1. Market size, by country, 2013-2024 (USD Million)
   6. HIV market
      1. Market size, by country, 2013-2024 (USD Million)
   7. Hepatitis B
      1. Market size, by country, 2013-2024 (USD Million)
   8. Hepatitis C
      1. Market size, by country, 2013-2024 (USD Million)
   9. HPV
      1. Market size, by country, 2013-2024 (USD Million)
   10. STD
       1. Market size, by country, 2013-2024 (USD Million)
       2. Chlamydia
          1. Market size, by country, 2013-2024 (USD Million)
       3. Gonorrhea
          1. Market size, by country, 2013-2024 (USD Million)
       4. Others
          1. Market size, by country, 2013-2024 (USD Million)
   11. Dengue
       1. Market size, by country, 2013-2024 (USD Million)
3. H.pylori
   1. Market size, by country, 2013-2024 (USD Million)
4. TORCH
   1. Market size, by country, 2013-2024 (USD Million)
5. Others
   1. Market size, by country, 2013-2024 (USD Million)
6. Blood screening
   1. Market size, by country, 2013-2024 (USD Million)
7. Genetic testing
   1. Market size, by country, 2013-2024 (USD Million)
8. Oncology testing
   1. Market size, by country, 2013-2024 (USD Million)

Chapter 5.North America Molecular Diagnostics Market, By Technology

1. Key segment trend
2. PCR
   1. Market size, by country, 2013-2024 (USD Million)
3. In-situ hybridization
   1. Market size, by country, 2013-2024 (USD Million)
4. Chips & microarrays
   1. Market size, by country, 2013-2024 (USD Million)
5. Mass spectroscopy
   1. Market size, by country, 2013-2024 (USD Million)
6. Sequencing
   1. Market size, by country, 2013-2024 (USD Million)
7. Isothermal amplification
   1. Market size, by country, 2013-2024 (USD Million)
8. Others
   1. Market size, by country, 2013-2024 (USD Million)

Chapter 6.North America Molecular Diagnostics Market, By Country

1. Key country trend
2. North America
   1. Market size, by country, 2013 - 2024(USD Million)
   2. Market size, by application, 2013 - 2024(USD Million)
   3. Market size, by technology, 2013 - 2024(USD Million)
   4. U.S.
      1. Market size, by application, 2013 - 2024(USD Million)
      2. Market size, by technology, 2013 - 2024(USD Million)
   5. Canada
      1. Market size, by application, 2013 - 2024(USD Million)
      2. Market size, by technology, 2013 - 2024(USD Million)

Chapter 7.Company Profiles

1. Abbott Molecular
   1. Business overview
   2. Financial data
   3. Product landscape
   4. Strategic outlook
   5. SWOT analysis
2. Agilent (Dako)
   1. Business overview
   2. Financial data
   3. Product landscape
   4. Strategic outlook
   5. SWOT analysis
3. Alere Inc.
   1. Business overview
   2. Financial data
   3. Product landscape
   4. Strategic outlook
   5. SWOT analysis
4. Analytik Jena AG
   1. Business overview
   2. Financial data
   3. Product landscape
   4. Strategic outlook
   5. SWOT analysis
5. Becton Dickinson
   1. Business overview
   2. Financial data
   3. Product landscape
   4. Strategic outlook
   5. SWOT analysis
6. Biocartis Group
   1. Business overview
   2. Financial data
   3. Product landscape
   4. Strategic outlook
   5. SWOT analysis
7. BioFire Diagnostics
   1. Business overview
   2. Financial data
   3. Product landscape
   4. Strategic outlook
   5. SWOT analysis
8. Biomerieux
   1. Business overview
   2. Financial data
   3. Product landscape
   4. Strategic outlook
   5. SWOT analysis
9. Bio-Rad Laboratories
   1. Business overview
   2. Financial data
   3. Product landscape
   4. Strategic outlook
   5. SWOT analysis
10. Bio-Techne
    1. Business overview
    2. Financial data
    3. Product landscape
    4. Strategic outlook
    5. SWOT analysis
11. Cephied
    1. Business overview
    2. Financial data
    3. Product landscape
    4. Strategic outlook
    5. SWOT analysis
12. Cleaver Scientific
    1. Business overview
    2. Financial data
    3. Product landscape
    4. Strategic outlook
    5. SWOT analysis
13. CombiMatrix
    1. Business overview
    2. Financial data
    3. Product landscape
    4. Strategic outlook
    5. SWOT analysis
14. Danaher Corporation
    1. Business overview
    2. Financial data
    3. Product landscape
    4. Strategic outlook
    5. SWOT analysis
15. GenMark Diagnostics
    1. Business overview
    2. Financial data
    3. Product landscape
    4. Strategic outlook
    5. SWOT analysis
16. Genomic Health, Inc.
    1. Business overview
    2. Financial data
    3. Product landscape
    4. Strategic outlook
    5. SWOT analysis
17. Hologic (Gen Probe)
    1. Business overview
    2. Financial data
    3. Product landscape
    4. Strategic outlook
    5. SWOT analysis
18. HTG Molecular Diagnostics
    1. Business overview
    2. Financial data
    3. Product landscape
    4. Strategic outlook
    5. SWOT analysis
19. MDx Health
    1. Business overview
    2. Financial data
    3. Product landscape
    4. Strategic outlook
    5. SWOT analysis
20. Myriad Genetics
    1. Business overview
    2. Financial data
    3. Product landscape
    4. Strategic outlook
    5. SWOT analysis
21. Novartis
    1. Business overview
    2. Financial data
    3. Product landscape
    4. Strategic outlook
    5. SWOT analysis
22. Qiagen
    1. Business overview
    2. Financial data
    3. Product landscape
    4. Strategic outlook
    5. SWOT analysis
23. Roche Diagnostics
    1. Business overview
    2. Financial data
    3. Product landscape
    4. Strategic outlook
    5. SWOT analysis
24. Rosetta Genomics
    1. Business overview
    2. Financial data
    3. Product landscape
    4. Strategic outlook
    5. SWOT analysis
25. SCILOGEX, LLC
    1. Business overview
    2. Financial data
    3. Product landscape
    4. Strategic outlook
    5. SWOT analysis
26. Siemens Healthcare
    1. Business overview
    2. Financial data
    3. Product landscape
    4. Strategic outlook
    5. SWOT analysis
27. Sysmex
    1. Business overview
    2. Financial data
    3. Product landscape
    4. Strategic outlook
    5. SWOT analysis

Data Tables

TABLE 1.North America molecular diagnostics industry 360⁰ synopsis, 2013 – 2024

TABLE 2.Industry impact forces

TABLE 3.North America Molecular Diagnostics market, pipeline analysis

TABLE 4.Infectious disease market size, by country, 2013 – 2024 (USD Million)

TABLE 5.Flu market size, by country, 2013 – 2024 (USD Million)

TABLE 6.RSV virus market size, by country, 2013 – 2024 (USD Million)

TABLE 7.Tuberculosis market size, by country, 2013 – 2024 (USD Million)

TABLE 8.Meningitis market size, by country, 2013 – 2024 (USD Million)

TABLE 9.HIV market size, by country, 2013 – 2024 (USD Million)

TABLE 10.Hepatitis C market size, by country, 2013 – 2024 (USD Million)

TABLE 11.Hepatitis B market size, by country, 2013 – 2024 (USD Million)

TABLE 12.HPV market size, by country, 2013 – 2024 (USD Million)

TABLE 13.STD market size, by country, 2013 – 2024 (USD Million)

TABLE 14.Chlamydia market size, by country, 2013 – 2024 (USD Million)

TABLE 15.Gonorrhea market size, by country, 2013 – 2024 (USD Million)

TABLE 16.Others market size, by country, 2013 – 2024 (USD Million)

TABLE 17.Dengue market size, by country, 2013 – 2024 (USD Million)

TABLE 18.H. Pylori market size, by country, 2013 – 2024 (USD Million)

TABLE 19.TORCH market size, by country, 2013 – 2024 (USD Million)

TABLE 20.Others market size, by country, 2013 – 2024 (USD Million)

TABLE 21.Blood screening market size, by country, 2013 – 2024 (USD Million)

TABLE 22.Genetic testing market size, by country, 2013 – 2024 (USD Million)

TABLE 23.Oncology testing market size, by country, 2013 – 2024 (USD Million)

TABLE 24.PCR testing market size, by country, 2013 – 2024 (USD Million)

TABLE 25.In situ hybridization market size, by country, 2013 – 2024 (USD Million)

TABLE 26.Chips and microarrays testing market size, by country, 2013 – 2024 (USD Million)

TABLE 27.Mass spectrometry testing market size, by country, 2013 – 2024 (USD Million)

TABLE 28.Sequencing testing market size, by country, 2013 – 2024 (USD Million)

TABLE 29.Isothermal amplification testing market size, by country, 2013 – 2024 (USD Million)

TABLE 30.Others market size, by country, 2013 – 2024 (USD Million)

TABLE 31.North America molecular diagnostics market size, by country, 2013 - 2024 (USD Million)

TABLE 32.North America molecular diagnostics market size, by application, 2013 - 2024 (USD Million)

TABLE 33.North America molecular diagnostics market size, by infectious disease, 2013 - 2024 (USD Million)

TABLE 34.North America molecular diagnostics market size, by STDs, 2013 - 2024 (USD Million)

TABLE 35.North America molecular diagnostics market size, by technology, 2013 - 2024 (USD Million)

TABLE 36.U.S. molecular diagnostics market size, by application, 2013 - 2024 (USD Million)

TABLE 37.U.S. molecular diagnostics market size, by infectious disease, 2013 - 2024 (USD Million)

TABLE 38.U.S. molecular diagnostics market size, by STDs, 2013 - 2024 (USD Million)

TABLE 39.U.S. molecular diagnostics market size, by technology, 2013 - 2024 (USD Million)

TABLE 40.Canada molecular diagnostics market size, by application, 2013 - 2024 (USD Million)

TABLE 41.Canada molecular diagnostics market size, by infectious disease, 2013 - 2024 (USD Million)

TABLE 42.Canada North America Molecular Diagnostics market size, by STDs, 2013 - 2024 (USD Million)

TABLE 43.Canada molecular diagnostics market size, by technology, 2013 - 2024 (USD Million)

CHARTS & FIGURES

FIG 1.Industry segmentation

FIG 2.North America molecular diagnostics market, 2013 – 2024 (USD Million)

FIG 3.Growth potential analysis, by application

FIG 4.Growth potential analysis, by technology

FIG 5.Comparative study between conventional culture method and molecular testing method

FIG 6.Porter’s analysis

FIG 7.Strategy dashboard

FIG 8.PESTEL analysis